Analystreport

Gossamer Bio (NASDAQ:GOSS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.

Gossamer Bio, Inc.  (GOSS) 
Last gossamer bio, inc. earnings: 3/24 07:00 am Check Earnings Report